Tag: Aspirin
ASTRO: NSAIDs May Offer Benefit to Head & Neck Cancer Patients
Benefit not significant for aspirin use in patients with non-small cell lung cancer undergoing SBRT
Combo Antithrombotic Therapy Increases Bleeding Risk
Greatest risk seen in first year of treatment, but benefits of combo therapy continue after one year
Aspirin for Primary Prevention May Offer Net Benefit for Some
Subgroups with net benefit had higher baseline CVD risk, higher levels of most established CVD risk factors
Aspirin May Improve Liver Function After Embolization of HCC
Study suggests aspirin is hepatoprotective, improves survival by reducing liver inflammation
Almost One in Four Adults ≥40 Takes Aspirin for CVD Prevention
Nearly half of U.S. adults aged 70 years or older without cardiovascular disease take aspirin
Providers, Peers Influence Aspirin Use Among African-Americans
Positive social environment around a prevention approach may increase uptake, authors say
Intracranial Hemorrhage Risk Up With Low-Dose Aspirin
Caution advised for low-dose aspirin in individuals without symptomatic cardiovascular disease
Oral Aspirin Does Not Up FIT Test Sensitivity for ID’ing CRC
Sensitivity not significantly increased in aspirin versus placebo group at two cutoffs
Low-Dose Aspirin Does Not Cut Death From Prostate Cancer
But during extended exposure periods of at least five years, low-dose aspirin may cut mortality
Prognostic Bleeding Risk Models Developed for Aspirin Use
Models developed for individuals in whom aspirin is being considered for primary prevention of CVD
